Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis

NCT01385826 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Uveitis
Juvenile Arthritis

Interventions

DRUG: Anti-tumor necrosis factor alpha monoclonal antibody
DRUG: placebo

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]